Invention Grant
- Patent Title: Arylalkyl-and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
-
Application No.: US15446852Application Date: 2017-03-01
-
Publication No.: US09957238B2Publication Date: 2018-05-01
- Inventor: Michael R. Johnson
- Applicant: Parion Sciences, Inc.
- Applicant Address: US NC Durham
- Assignee: Parion Sciences, Inc.
- Current Assignee: Parion Sciences, Inc.
- Current Assignee Address: US NC Durham
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: C07D241/32
- IPC: C07D241/32 ; A61K31/4965 ; A61K45/06 ; A61K33/14 ; A61K31/047

Abstract:
The present invention relates to the compound of the formula: or pharmaceutically acceptable salts thereof, as well as compositions containing the same, processes for the preparation of the same, and therapeutic methods of use therefore in promoting hydration of mucosal surfaces and the treatment of diseases including chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, acute and chronic bronchitis, cystic fibrosis, emphysema, and pneumonia.
Public/Granted literature
- US20170305868A1 ARYLALKYL-AND ARYLOXYALKYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS Public/Granted day:2017-10-26
Information query
IPC分类: